title: Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.
abstract: The outcome of infection with hepatitis C virus (HCV) varies greatly. The virus associates with serum lipoproteins, including those containing apolipoprotein E (apoE) and apolipoprotein B (apoB), and may enter cells via the low-density lipoprotein receptor (LDLR). ApoE genotypes can affect the extent of damage in diseases caused by 2 other viruses--herpes simplex virus type 1 (HSV1; in Alzheimer's disease and herpes labialis) and human immunodeficiency virus (HIV). We therefore investigated whether specific apoE and apoB alleles were associated with different outcomes of HCV infection. A total of 156 anti-HCV-positive patients and 104 non-HCV-infected patients were studied. Liver biopsy specimens from patients with chronic HCV infection (n = 111) were assessed for disease severity by the Knodell system. ApoE and apoB genotypes were determined by standard polymerase chain reaction (PCR) methods. There was no significant difference among the apoE genotypes of HCV-infected subjects compared with previously published population data, or between HCV-RNA positive or negative patients. However, chronically HCV-infected subjects with mild liver disease (n = 65) had a significantly higher apoE-epsilon 4 allele frequency (20.0%) than those (n = 46) with severe disease (6.5%). ApoB alleles alone or in combination with apoE were not associated with mild or severe disease. The overall apoE allele frequencies of patients with liver disease not caused by HCV were similar to those of the total HCV group and in contrast to the HCV patients, the apoE allele frequencies were similar in those patients with no or mild fibrosis as compared with those with bridging fibrosis or cirrhosis. In conclusion, carriage of an apoE-epsilon 4 allele may be protective against liver damage caused by HCV, but not against damage due to various nonviral causes. This is yet another case in which apoE may determine the severity of a viral disease.
authors.affiliation: Molecular Neurobiology Laboratory, Department of Optometry & Neuroscience, University of Manchester Institute of Science and Technology, Manchester, UK.
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Wozniak
authors.forename: Ruth F
authors.initials: RF
authors.lastname: Itzhaki
authors.forename: E Brian
authors.initials: EB
authors.lastname: Faragher
authors.forename: Martin W
authors.initials: MW
authors.lastname: James
authors.forename: Steven D
authors.initials: SD
authors.lastname: Ryder
authors.forename: William L
authors.initials: WL
authors.lastname: Irving
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D053327:Apolipoprotein E4; D001055:Apolipoproteins B / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D019698:Hepatitis C, Chronic / Q000235:genetics*; D006801:Humans; D008103:Liver Cirrhosis / Q000235:genetics / Q000821:virology; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic
chemical_list: D053327:Apolipoprotein E4; D001055:Apolipoproteins B; D001057:Apolipoproteins E